Search Results

There are 6634 results for: content related to: Canadian Estimates of Health Care Utilization Costs for Rheumatoid Arthritis Patients With and Without Therapy With Biologic Agents

  1. You have free access to this content
    Etanercept for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell and George A Wells

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD004525.pub2

  2. You have free access to this content
    Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  3. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell and George A Wells

    Published Online : 17 NOV 2016, DOI: 10.1002/14651858.CD012437

  4. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  5. You have free access to this content
    Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 66, Issue 8, August 2014, Pages: 1152–1158, Daniel H. Solomon, Chris Tonner, Bing Lu, Seoyoung C. Kim, John Z. Ayanian, M. Alan Brookhart, Jeffrey N. Katz and Ed Yelin

    Version of Record online : 28 JUL 2014, DOI: 10.1002/acr.22286

  6. You have free access to this content
    Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 630–638, Leslie R. Harrold, J. Timothy Harrington, Jeffrey R. Curtis, Daniel E. Furst, Mary Jane Bentley, Ying Shan, George Reed, Joel Kremer and Jeffrey D. Greenberg

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.33380

  7. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Lara J Maxwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor, Peter Tugwell and George A Wells

    Published Online : 10 MAR 2017, DOI: 10.1002/14651858.CD012591

  8. You have free access to this content
    Patterns of Disease-Modifying Antirheumatic Drug Use in Rheumatoid Arthritis Patients After 2002: A Systematic Review

    Arthritis Care & Research

    Volume 65, Issue 12, December 2013, Pages: 1927–1935, Gabriela Schmajuk, Daniel H. Solomon and Jinoos Yazdany

    Version of Record online : 27 NOV 2013, DOI: 10.1002/acr.22084

  9. You have free access to this content
    Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983–2009

    Arthritis Care & Research

    Volume 65, Issue 9, September 2013, Pages: 1529–1533, Seoyoung C. Kim, Ed Yelin, Chris Tonner and Daniel H. Solomon

    Version of Record online : 26 AUG 2013, DOI: 10.1002/acr.21997

  10. You have free access to this content
    Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs

    Arthritis & Rheumatology

    Volume 68, Issue 1, January 2016, Pages: 67–76, Neil A. Accortt, Machaon M. Bonafede, David H. Collier, Jan Iles and Jeffrey R. Curtis

    Version of Record online : 23 DEC 2015, DOI: 10.1002/art.39416

  11. You have free access to this content
    Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

    Arthritis Care & Research

    Volume 67, Issue 9, September 2015, Pages: 1210–1218, Jinoos Yazdany, Chris Tonner and Gabriela Schmajuk

    Version of Record online : 26 AUG 2015, DOI: 10.1002/acr.22580

  12. You have free access to this content
    Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: Results from the Consortium of Rheumatology Researchers of North America registry

    Arthritis Care & Research

    Volume 63, Issue 6, June 2011, Pages: 856–864, Daniel E. Furst, Aileen L. Pangan, Leslie R. Harrold, Hong Chang, George Reed, Joel M. Kremer and Jeffrey D. Greenberg

    Version of Record online : 31 MAY 2011, DOI: 10.1002/acr.20452

  13. You have free access to this content
    Association of Socioeconomic Status With Treatment Delays, Disease Activity, Joint Damage, and Disability in Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 67, Issue 7, July 2015, Pages: 940–946, Emily Molina, Inmaculada del Rincon, Jose Felix Restrepo, Daniel F. Battafarano and Agustin Escalante

    Version of Record online : 25 JUN 2015, DOI: 10.1002/acr.22542

  14. You have free access to this content
    Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis

    Arthritis Care & Research

    Volume 63, Issue 10, October 2011, Pages: 1415–1424, Vivian K. Kawai, Carlos G. Grijalva, Patrick G. Arbogast, Jeffrey R. Curtis, Daniel H. Solomon, Elizabeth Delzell, Lang Chen, Rita Ouellet-Hellstrom, Lisa Herrinton, Liyan Liu, Edward F. Mitchel Jr., C. Michael Stein and Marie R. Griffin

    Version of Record online : 27 SEP 2011, DOI: 10.1002/acr.20550

  15. You have full text access to this OnlineOpen article
    No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

    Arthritis & Rheumatism

    Volume 62, Issue 11, November 2010, Pages: 3145–3153, Mark Lunt, Kath D. Watson, William G. Dixon, British Society for Rheumatology Biologics Register Control Centre Consortium, Deborah P. M. Symmons, Kimme L. Hyrich and British Society for Rheumatology Biologics Register

    Version of Record online : 29 OCT 2010, DOI: 10.1002/art.27660

  16. You have free access to this content
    The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

    Arthritis & Rheumatism

    Volume 60, Issue 5, May 2009, Pages: 1222–1231, Vappu Rantalaiho, Markku Korpela, Pekka Hannonen, Hannu Kautiainen, Salme Järvenpää, Marjatta Leirisalo-Repo, Markku Hakala, Kari Puolakka, Heikki Julkunen, Riitta Luosujärvi, Timo Möttönen and FIN-RACo Trial Group

    Version of Record online : 29 APR 2009, DOI: 10.1002/art.24447

  17. You have free access to this content
    Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New-Onset Polyarticular Juvenile Idiopathic Arthritis

    Arthritis Care & Research

    Volume 66, Issue 7, July 2014, Pages: 1063–1072, Sarah Ringold, Pamela F. Weiss, Robert A. Colbert, Esi Morgan DeWitt, Tzielan Lee, Karen Onel, Sampath Prahalad, Rayfel Schneider, Susan Shenoi, Richard K. Vehe, Yukiko Kimura and for the Juvenile Idiopathic Arthritis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance

    Version of Record online : 26 JUN 2014, DOI: 10.1002/acr.22259

  18. You have free access to this content
    Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey

    Arthritis Care & Research

    Volume 64, Issue 2, February 2012, Pages: 184–189, Daniel H. Solomon, John Z. Ayanian, Ed Yelin, Tamara Shaykevich, M. Alan Brookhart and Jeffrey N. Katz

    Version of Record online : 25 JAN 2012, DOI: 10.1002/acr.20674

  19. You have free access to this content
    Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014

    Arthritis & Rheumatology

    Volume 68, Issue 7, July 2016, Pages: 1588–1595, Jeffrey A. Sparks, Alexis A. Krumme, William H. Shrank, Olga S. Matlin, Gregory Brill, Edmund J. Pezalla, Niteesh K. Choudhry and Daniel H. Solomon

    Version of Record online : 24 JUN 2016, DOI: 10.1002/art.39617

  20. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2